The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.
AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...
Copaxone is available in two strengths: 20 milligrams (mg) per 1 milliliter (mL) of liquid solution and 40 mg/mL. The drug comes in single-dose prefilled syringes for injection under the skin. For all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback